Trajectories of health-related quality of life and psychological distress in patients with colorectal cancer: A population-based studySeyed M. Qaderi, Ankie M.T. van der Velden, J. Van Der Heijden et al.|European Journal of Cancer|2021Cited by 55
Phase I evaluation of cediranib, a selective VEGFR signalling inhibitor, in combination with gefitinib in patients with advanced tumoursHester van Cruijsen, Giuseppe Giaccone, Emile E. Voest et al.|European Journal of Cancer|2010Cited by 54
The Prospective Dutch Colorectal Cancer (PLCRC) cohort: real-world data facilitating research and clinical careJeroen W. G. Derksen, Hein B.A.C. Stockmann, Geraldine R. Vink et al.|Scientific Reports|2021Cited by 40
Quality of Life and Survival of Metastatic Colorectal Cancer Patients Treated With Trifluridine-Tipiracil (QUALITAS)Patricia A. H. Hamers, Agnès J. van de Wouw, Hester van Cruijsen et al.|Clinical Colorectal Cancer|2022Cited by 16
Evaluation of AZD2171, an oral, highly potent and selective VEGFR signaling inhibitor, in renal cell carcinoma (RCC): Combined results from two phase I studiesC. van Herpen, Giuseppe Giaccone, Joachim Drevs et al.|Journal of Clinical Oncology|2007Cited by 10